Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Jabrehoo Med Tech

Request full access

Genetic technology company based in Beijing

Daxing District, ChinaFounded 2011Biotech & Life Sciences

About Jabrehoo Med Tech

Established in June 2011, Beijing Jabrehoo Med Tech Co., Ltd. operates at the intersection of high-throughput gene sequencing, big data, and clinical medical applications, with a specialized focus on reproductive and genetic health. The company was founded by Fei Jia, who serves as the Chairman. Jabrehoo Med Tech provides comprehensive, one-stop solutions for couples undergoing assisted reproduction, individuals facing infertility, and those planning for pregnancy.

The firm's business model is built around an integrated industrial chain that includes technology research and development, product manufacturing, clinical testing services, a proprietary testing database, and the supply of equipment and consumables for assisted reproduction. Its clientele primarily consists of reproductive medicine centers, with its PGT (Preimplantation Genetic Testing) series products covering over 80% of PGD-qualified centers in mainland China. Revenue is generated through the sale of these testing products, which include kits for various genetic screenings, and integrated service platforms that offer solutions for laboratory construction and genetic analysis.

Jabrehoo’s core service portfolio is segmented into prenatal, pre-implantation, and postnatal stages. The company offers a suite of clinical diagnostic products, such as carrier screening for monogenic diseases, tests for infertility-related genetic causes, and non-invasive prenatal testing (NIPT). A key offering is its Preimplantation Genetic Testing (PGT) platform—often associated with third-generation IVF technology—which screens embryos for genetic diseases and chromosomal abnormalities before implantation. The company has processed over 300,000 embryos for PGT-A testing and has established a substantial database for single-gene disease testing, having analyzed over 21,600 pedigrees for more than 1,000 monogenic conditions. To support its clinical partners, Jabrehoo also provides integrated solutions for establishing and certifying assisted reproduction laboratories, including high-throughput sequencing and genetic analysis capabilities.

Source: Dealroom company data

At a glance

Status
Operational
Employees
15
Open positions
1
Dealroom signal
24.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, DNA, Genetics and genomics, Genome Engineering, Biotech and Pharma, Hard Tech, DT and LS, science-based

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC Aug 2020 $14M $57M Apricot Capital —
SEED✓Equity / VC Apr 2018 $0 — ShenZhen GTJA Investment Group —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Jabrehoo Med Tech website traffic

Latest recorded traffic for Jabrehoo Med Tech is 290 monthly website visits, up 866.7% over the last three months. Jabrehoo Med Tech's team grew 0% over the past year.

Latest monthly visits290 3-month web change+866.7% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Jabrehoo Med Tech in the Daxing District ecosystem

Live from Dealroom

The Jabrehoo Med Tech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • ShenZhen GTJA Investment Group

Series A1 investor entered at this stage

  • Apricot Capital

Other known investors1 additional known investor

  • Tengye Venture Capital
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Jabrehoo Med Tech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Jabrehoo Med Tech’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.